Sensorion to Present at Two Conferences on March 16th 2021 Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces the participation of management in two separate virtual conferences on March 16, 2021. CEO Nawal Ouzren will present an overview of Sensorion's strategy in a virtual CEO Roundtable event at the WuXi Healthcare Forum 2021, an investor and partnering meeting. The presentation will be followed by an open Q&A session. Date: Tuesday, March 16, 2021 Time: 3.45 pm-4.15 pm CET (09.45-10.15 Eastern time)